Vancomycin Dosing for Cellulitis
For most adults with uncomplicated MRSA cellulitis who have normal renal function and are not obese, vancomycin 1 g IV every 12 hours is adequate, and trough monitoring is not required. 1
Dosing Algorithm
Standard Cellulitis (Non-severe)
- Dose: 1 g IV every 12 hours (or 15-20 mg/kg/dose every 8-12 hours, not to exceed 2 g per dose) 1
- Infusion: Administer over at least 60 minutes 2
- Duration: 7-14 days, individualized based on clinical response 3
- Monitoring: Trough monitoring is not required for patients with normal renal function who are not obese 1
Severe/Complicated Cellulitis (e.g., necrotizing fasciitis, extensive disease, systemic toxicity)
- Loading dose: Consider 25-30 mg/kg (actual body weight) for seriously ill patients 1
- Infuse over 2 hours with antihistamine premedication to reduce red man syndrome risk 1
- Maintenance: 15-20 mg/kg/dose every 8-12 hours 1
- Target trough: 15-20 mcg/mL 1
- Monitoring: Obtain trough before 4th or 5th dose at steady state 1
When to Monitor Troughs
Mandatory monitoring for: 1
- Morbid obesity
- Renal dysfunction (including dialysis patients)
- Fluctuating volumes of distribution
- Severe/complicated skin and soft tissue infections
Renal Adjustment
For impaired renal function, dose based on creatinine clearance: 2
- CrCl 100 mL/min: 1,545 mg/24h
- CrCl 50 mL/min: 770 mg/24h
- CrCl 10 mL/min: 155 mg/24h
Initial dose should be at least 15 mg/kg even with mild-moderate renal impairment 2
Key Clinical Considerations
Distinguishing Purulent vs Non-purulent Cellulitis
- Purulent cellulitis (drainage/exudate without drainable abscess): Empiric MRSA coverage recommended 3
- Non-purulent cellulitis (no drainage/exudate, no abscess): Empiric beta-hemolytic streptococci coverage; add MRSA coverage only if no response to beta-lactam or systemic toxicity present 3
Alternative to Vancomycin for Hospitalized Patients
Other IV options for complicated SSTI include: 3
- Linezolid 600 mg IV/PO twice daily
- Daptomycin 4 mg/kg IV once daily
- Telavancin 10 mg/kg IV once daily
- Clindamycin 600 mg IV/PO three times daily (if local resistance <10%)
Common Pitfalls
- Over-monitoring: Most cellulitis cases don't need trough monitoring—reserve for severe infections or high-risk patients 1
- Bilateral cellulitis: Rare; consider alternative diagnoses like venous stasis dermatitis 4
- Excessive dosing: Traditional 1 g every 12 hours achieves adequate tissue penetration for most SSTI without nephrotoxicity risk 1
- MIC considerations: If vancomycin MIC >2 mcg/mL, switch to alternative agent 1
Updated Guidance on AUC Monitoring
While 2020 guidelines recommend AUC-guided dosing (target AUC/MIC 400-600) for serious MRSA infections 5, this applies primarily to bacteremia, endocarditis, osteomyelitis, and pneumonia—not routine cellulitis. For uncomplicated cellulitis, trough-based or even empiric dosing without monitoring remains appropriate 1, 6.